# Outpatient Lung Impedance-Guided Preventive Therapy in Patients With Chronic Heart Failure (CHF)

> **NCT01315223** · PHASE3 · UNKNOWN · sponsor: **Hillel Yaffe Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Chronic Congestive Heart Failure

## Interventions

- **OTHER:** Lung impedence-guided treatment

## Key facts

- **NCT ID:** NCT01315223
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01315223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01315223, "Outpatient Lung Impedance-Guided Preventive Therapy in Patients With Chronic Heart Failure (CHF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01315223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*